ScholarIQanswers from OpenAlex & ORCID
Lucely Cetina
ResearcherPublications, citations & collaboration network
Lucely Cetina is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Lucely Cetina have?
ScholarIQindexed works
Lucely Cetina has 110 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Lucely Cetina have?
ScholarIQcitation count
Lucely Cetina has 2,908 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Lucely Cetina?
ScholarIQh-index
Lucely Cetina has an h-index of 29 in OpenAlex.
What is the i10-index of Lucely Cetina?
ScholarIQi10-index
Lucely Cetina has an i10-index of 57 in OpenAlex.
What is the ORCID of Lucely Cetina?
ScholarIQorcid
The ORCID for Lucely Cetina is on the source record.
What is the OpenAlex record for Lucely Cetina?
ScholarIQopenalex
The OpenAlex for Lucely Cetina is on the source record.
What are the most-cited papers on Lucely Cetina?
ScholarIQmost cited works
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
Myrna Candelaria, Dolores Gallardo‐Rincón, Claudia Arce, Lucely Cetina, José Luis Aguilar-Ponce, Óscar Arrieta, Aurora González‐Fierro, Alma Chávez‐Blanco, Erik de la Cruz-Hernandez, Maria Fernanda Vieira Cunha Camargo, Catalina Trejo‐Becerril, Enrique Pérez‐Cárdenas, Carlos Pérez‐Plasencia, Lucía Taja‐Chayeb, Talía Wegman-Ostrosky, Alma Luísa Revilla Vázquez, Alfonso Dueñas‐González
Epigenetics of cervical cancer. An overview and therapeutic perspectives
Alfonso Dueñas‐González, Marcela Lizano, Myrna Candelaria, Lucely Cetina, Claudia Arce, Eduardo Cervera
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes
Pilar Zambrano, Blanca Segura‐Pacheco, Enrique Pérez‐Cárdenas, Lucely Cetina, Alma Luísa Revilla Vázquez, Lucía Taja‐Chayeb, Alma Chávez‐Blanco, Enrique Ángeles, Gustavo Cabrera, Karina Sandoval, Catalina Trejo‐Becerril, José Chanona-Vilchis, Alfonso Dueñas‐González
A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results
Jaime Coronel, Lucely Cetina, Irlanda Pacheco, Catalina Trejo‐Becerril, Aurora González‐Fierro, Erick de la Cruz‐Hernandez, Enrique Pérez‐Cárdenas, Lucía Taja‐Chayeb, Daymi Arias-Bofill, Myrna Candelaria, Sílvia Vidal, Alfonso Dueñas‐González
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study
Alma Chávez‐Blanco, Blanca Segura‐Pacheco, Enrique Pérez‐Cárdenas, Lucía Taja‐Chayeb, Lucely Cetina, Myrna Candelaria, David Cantú de León, Aurora González‐Fierro, Patricia García‐López, Pilar Zambrano, Carlos Pérez‐Plasencia, Gustavo Cabrera, Catalina Trejo‐Becerril, Enrique Ángeles, Alfonso Dueñas‐González